Science News

Researchers at Children’s Hospital of Philadelphia and the School of Engineering and Applied Science at the University of Pennsylvania have identified ionizable lipid nanoparticles that could be used to deliver mRNA as part of fetal therapy. The proof-of-concept study, published today in Science Advances, engineered and screened a number of lipid nanoparticle formulations for targeting mouse fetal organs and has laid the groundwork for testing potential therapies to treat genetic diseases before birth.
Read More

Comments

Say Something, or email me at oren@eyalo.com

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Loading Disqus Comments ...

No Trackbacks.